Capoten

• Generic Name: captopril
• Brand Name: Capoten
• Drug Class: ACE Inhibitors

Capoten (Captopril) side effects drug center

• Related Drugs
  Accupril Altace Altace Capsules Byetta Capozide Dutoprol Humalog Humulin N Humulin R Inspra Irbesartan Generic Isoptin Isuprel Janumet Jenloga Jentadueto Kapspargo Sprinkle Lotensin Lotensin Hct Lotrel Mavik Methyldopa Monopril Prandimet Prandin Prestalia Prinivil Prinzide Tekturna Vaseretic Vasotec Verquvo Vyndaqel and Vyndamax Zaroxolyn Zemplar Zestoretic Zestril
• Health Resources
  Congestive Heart Failure (CHF) Diabetes (Type 1 and Type 2) Heart Attack (Myocardial Infarction) Kidney (Renal) Failure
• Related Supplements
  Alpha-Linolenic Acid Beer Black Tea Blond Psyllium Calcium Chitosan Cocoa Cod Liver Oil Coenzyme Q-10 Creatine Fish Oil Garlic Hawthorn Iron L-Arginine L-Carnitine N-Acetyl Cysteine Olive Potassium Propionyl-L-Carnitine Pycnogenol Stevia Sweet Orange Taurine Terminalia Vitamin D Wheat Bran Wine
• Drug Comparison
  Capoten vs. Aceon Capoten vs. Altace Capoten vs. Diovan Capoten vs. Jenloga Capoten vs. Norvasc Capoten vs. Prinivil, Qbrelis, Zestril

 

PROFESSIONAL

CONSUMER

SIDE EFFECTS

• Overview
• Consumer Information
• Professional Information

 

Capoten Side Effects Center

What Is Capoten?

Capoten (captopril) is an angiotensin converting enzyme (ACE) inhibitor prescribed for treating high blood pressure, heart failure, and for preventing kidney failure due to high blood pressure and diabetes. Capoten is available as a generic drug.

What Are Side Effects of Capoten?

Common side effects of Capoten include:

• a dry and persistent cough,
• abdominal pain,
• constipation,
• diarrhea,
• skin itching or rash,
• dizziness,
• lightheadedness,
• drowsiness,
• fatigue,
• headache,
• sleep problems (insomnia),
• loss of taste,
• loss of appetite,
• nausea,
• vomiting,
• dry mouth,
• sores inside your mouth or on your lips,
• numbness in the hands or feet,
• kidney failure and
• increased levels of potassium in the blood.

Dosage for Capoten?

Capoten dose ranges from 25-150 mg two or three times daily. Capoten may interact with gold injections, lithium, potassium supplements, salt substitutes that contain potassium, drugs that can dilate blood vessels, aspirin or other NSAIDs (nonsteroidal anti-inflammatory drugs) or diuretics (water pills). Tell your doctor all medications and supplements you use.

What Drugs, Substances, or Supplements Interact with Capoten?

Capoten During Pregnancy and Breastfeeding

Capoten is not recommended for use during pregnancy; it can harm a fetus. Talk to your doctor about using birth control while taking Capoten. Capoten passes into breast milk and may harm a nursing baby. Breastfeeding while using Capoten is not recommended.

Additional Information

Our Capoten Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

 

Capoten Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; severe stomach pain; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

• a light-headed feeling, like you might pass out;
• little or no urination, or urinating more than usual;
• shortness of breath (even with mild exertion), swelling, rapid weight gain;
• chest pain or pressure, pounding heartbeats or fluttering in your chest;
• high potassium--nausea, slow or unusual heart rate, weakness, loss of movement; or
• sudden weakness or ill feeling, fever, chills, sore throat, painful mouth sores, pain when swallowing, skin sores, cold or flu symptoms.

Common side effects may include:

• cough;
• flushing (warmth, redness, or tingly feeling);
• numbness, tingling, or burning pain in your hands or feet;
• loss of taste sensation; or
• mild skin itching or rash.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Capoten (Captopril)

 

Capoten Professional Information

SIDE EFFECTS

Reported incidences are based on clinical trials involving approximately 7000 patients.

Renal: About one of 100 patients developed proteinuria (see WARNINGS).

Each of the following has been reported in approximately 1 to 2 of 1000 patients and are of uncertain relationship to drug use: renal insufficiency, renal failure, nephrotic syndrome, polyuria, oliguria, and urinary frequency.

Hematologic: Neutropenia/agranulocytosis has occurred (see WARNINGS). Cases of anemia, thrombocytopenia, and pancytopenia have been reported.

Dermatologic: Rash, often with pruritus, and sometimes with fever, arthralgia, and eosinophilia, occurred in about 4 to 7 (depending on renal status and dose) of 100 patients, usually during the first four weeks of therapy. It is usually maculopapular, and rarely urticarial. The rash is usually mild and disappears within a few days of dosage reduction, short-term treatment with an antihistaminic agent, and/or discontinuing therapy; remission may occur even if captopril is continued. Pruritus, without rash, occurs in about 2 of 100 patients. Between 7 and 10 percent of patients with skin rash have shown an eosinophilia and/or positive ANA titers. A reversible associated pemphigoid-like lesion, and photosensitivity, have also been reported.

Flushing or pallor has been reported in 2 to 5 of 1000 patients.

Cardiovascular: Hypotension may occur; see WARNINGS and PRECAUTIONS: DRUG INTERACTIONS for discussion of hypotension with captopril therapy.

Tachycardia, chest pain, and palpitations have each been observed in approximately 1 of 100 patients.

Angina pectoris, myocardial infarction, Raynaud's syndrome, and congestive heart failure have each occurred in 2 to 3 of 1000 patients.

Dysgeusia: Approximately 2 to 4 (depending on renal status and dose) of 100 patients developed a diminution or loss of taste perception. Taste impairment is reversible and usually self-limited (2 to 3 months) even with continued drug administration. Weight loss may be associated with the loss of taste.

Angioedema: Angioedema involving the extremities, face, lips, mucous membranes, tongue, glottis or larynx has been reported in approximately one in 1000 patients. Angioedema involving the upper airways has caused fatal airway obstruction. (See WARNINGS: Head and Neck Angioedema, Intestinal Angioedema and PATIENT INFORMATION)

Cough: Cough has been reported in 0.5 to 2% of patients treated with captopril in clinical trials (see PRECAUTIONS: General, Cough).

The following have been reported in about 0.5 to 2 percent of patients but did not appear at increased frequency compared to placebo or other treatments used in controlled trials: gastric irritation, abdominal pain, nausea, vomiting, diarrhea, anorexia, constipation, aphthous ulcers, peptic ulcer, dizziness, headache, malaise, fatigue, insomnia, dry mouth, dyspnea, alopecia, paresthesias.

Other clinical adverse effects reported since the drug was marketed are listed below by body system. In this setting, an incidence or causal relationship cannot be accurately determined.

Body as a whole: Anaphylactoid reactions (see WARNINGS: Anaphylactoid and possible related reactions and PRECAUTIONS: Hemodialysis).

General: Asthenia, gynecomastia.

Cardiovascular: Cardiac arrest, cerebrovascular accident/insufficiency, rhythm disturbances, orthostatic hypotension, syncope.

Dermatologic: Bullous pemphigus, erythema multiforme (including Stevens-Johnson syndrome), exfoliative dermatitis.

Gastrointestinal: Pancreatitis, glossitis, dyspepsia.

Hematologic: Anemia, including aplastic and hemolytic.

Hepatobiliary: Jaundice, hepatitis, including rare cases of necrosis, cholestasis.

Metabolic: Symptomatic hyponatremia.

Musculoskeletal: Myalgia, myasthenia.

Nervous/Psychiatric: Ataxia, confusion, depression, nervousness, somnolence.

Respiratory: Bronchospasm, eosinophilic pneumonitis, rhinitis.

Special Senses: Blurred vision.

Urogenital: Impotence.

As with other ACE inhibitors, a syndrome has been reported which may include: fever, myalgia, arthralgia, interstitial nephritis, vasculitis, rash or other dermatologic manifestations, eosinophilia and an elevated ESR.

Altered Laboratory Findings

Serum Electrolytes: Hyperkalemia: small increases in serum potassium, especially in patients with renal impairment (see PRECAUTIONS).

Hyponatremia: particularly in patients receiving a low sodium diet or concomitant diuretics.

BUN/Serum Creatinine: Transient elevations of BUN or serum creatinine especially in volume or salt depleted patients or those with renovascular hypertension may occur. Rapid reduction of longstanding or markedly elevated blood pressure can result in decreases in the glomerular filtration rate and, in turn, lead to increases in BUN or serum creatinine.

Hematologic: A positive ANA has been reported.

Liver Function Tests: Elevations of liver transaminases, alkaline phosphatase, and serum bilirubin have occurred.

Read the entire FDA prescribing information for Capoten (Captopril)

&Copy; Capoten Patient Information is supplied by Cerner Multum, Inc. and Capoten Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.